# A Study of BGM0504 Evaluating Weight Loss in Overweight or Obese Chinese Subjects

> **NCT06973681** · PHASE2 · COMPLETED · sponsor: **BrightGene Bio-Medical Technology Co., Ltd.** · enrollment: 120 (actual)

## Conditions studied

- Overweight or Obesity

## Interventions

- **DRUG:** BGM0504
- **DRUG:** BGM0504
- **DRUG:** BGM0504
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06973681
- **Lead sponsor:** BrightGene Bio-Medical Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-13
- **Primary completion:** 2024-09-13
- **Final completion:** 2024-09-13
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2025-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06973681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06973681, "A Study of BGM0504 Evaluating Weight Loss in Overweight or Obese Chinese Subjects". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06973681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*